The estimated Net Worth of Aaron Berg is at least $5.44 Million dollars as of 2 August 2024. Mr. Berg owns over 160,000 units of Amarin Corp stock worth over $475,174 and over the last 5 years he sold AMRN stock worth over $2,104,295. In addition, he makes $2,859,220 as Senior Vice President und Chief Commercial Officer at Amarin Corp.
Aaron has made over 38 trades of the Amarin Corp stock since 2019, according to the Form 4 filled with the SEC. Most recently he bought 160,000 units of AMRN stock worth $102,400 on 2 August 2024.
The largest trade he's ever made was buying 160,000 units of Amarin Corp stock on 2 August 2024 worth over $102,400. On average, Aaron trades about 28,212 units every 43 days since 2019. As of 2 August 2024 he still owns at least 805,380 units of Amarin Corp stock.
You can see the complete history of Mr. Berg stock trades at the bottom of the page.
Aaron D. Berg serves as Senior Vice President, Chief Commercial Officer of the Company. Mr. Berg joined Amarin in November 2012 as Vice President, Marketing and Managed Care and has since served in roles of increasing responsibility, including as Senior Vice President, Marketing and Sales from February 2014 until April 2018. Since April 2018, Mr. Berg has served as our Senior Vice President and Chief Commercial Officer. Before joining Amarin, he served as President and Chief Executive Officer for Essentialis, Inc., a development stage pharmaceutical company, where he led the company’s work on triglyceride management. Prior to joining Essentialis, Mr. Berg served as Vice President of Marketing and Sales at Kos Pharmaceuticals, where he was instrumental in driving annual revenues approaching $1 billion until the acquisition of the company by Abbott Laboratories in December 2006. Mr. Berg began his pharmaceutical industry career as a sales representative with Bristol-Myers Squibb, followed by various commercial positions with Schering-Plough and GlaxoSmithKline. He obtained his B.S. in Business Management, Marketing from the University of Maryland.
As the Senior Vice President und Chief Commercial Officer of Amarin Corp, the total compensation of Aaron Berg at Amarin Corp is $2,859,220. There are 3 executives at Amarin Corp getting paid more, with John Thero having the highest compensation of $8,929,540.
Aaron Berg is 57, he's been the Senior Vice President und Chief Commercial Officer of Amarin Corp since 2018. There are 8 older and 8 younger executives at Amarin Corp. The oldest executive at Amarin Corp is Patrick O'Sullivan, 78, who is the Non-Executive Independent Director.
Aaron's mailing address filed with the SEC is C/O AMARIN PHARMA, INC., 440 US HIGHWAY 22, BRIDGEWATER, NJ, 08807.
Over the last 13 years, insiders at Amarin Corp have traded over $25,876,836 worth of Amarin Corp stock and bought 581,426 units worth $751,974 . The most active insiders traders include John F Thero, Steven B Ketchum und David M Stack. On average, Amarin Corp executives and independent directors trade stock every 10 days with the average trade being worth of $29,442. The most recent stock trade was executed by Aaron Berg on 2 August 2024, trading 160,000 units of AMRN stock currently worth $102,400.
amarin corporation plc is a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health. amarin's product development program leverages its extensive experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. vascepa® (icosapent ethyl) is amarin's first fda approved product and is available in the united states by prescription. for more information about vascepa visit www.vascepa.com.
Amarin Corp executives and other stock owners filed with the SEC include: